大禹生物
(920970)
| 流通市值：6.14亿 | | | 总市值：9.69亿 |
| 流通股本：7063.09万 | | | 总股本：1.11亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 92,453,169.97 | 62,181,019.92 | 29,472,938.03 | 122,511,959.17 |
| 营业收入 | 92,453,169.97 | 62,181,019.92 | 29,472,938.03 | 122,511,959.17 |
| 二、营业总成本 | 105,747,869.62 | 72,339,105.57 | 34,015,701.96 | 145,314,666.7 |
| 营业成本 | 73,629,440.26 | 50,207,269.85 | 23,576,272.31 | 91,912,539.65 |
| 税金及附加 | 1,487,349.48 | 1,298,260.14 | 142,082.26 | 2,397,329.45 |
| 销售费用 | 9,065,103.54 | 6,234,706.53 | 3,083,119.44 | 15,119,167.55 |
| 管理费用 | 14,234,373.81 | 9,728,005.77 | 4,843,486.54 | 24,924,712 |
| 研发费用 | 5,012,359.78 | 3,493,526.07 | 1,818,246.15 | 8,588,792.17 |
| 财务费用 | 2,319,242.75 | 1,377,337.21 | 552,495.26 | 2,372,125.88 |
| 其中:利息费用 | 2,305,545.64 | 1,376,682.4 | 524,228.08 | 2,391,334.78 |
| 其中:利息收入 | 28,061.05 | 21,798.9 | 9,454.26 | 41,525.87 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -2,360 | -2,360 | -2,360 | - |
| 加:投资收益 | 22,743.28 | 22,743.28 | -238.16 | - |
| 资产减值损失(新) | -664,313.34 | -664,313.34 | - | -3,608,656.5 |
| 信用减值损失(新) | -964,951.53 | -894,346.79 | -4,058.25 | -3,398,262.74 |
| 其他收益 | 4,285,298.3 | 2,686,315.27 | 1,311,514.33 | 6,528,999.18 |
| 四、营业利润 | -10,618,282.94 | -9,010,047.23 | -3,237,906.01 | -23,280,627.59 |
| 加:营业外收入 | 1.31 | 1.29 | 0.22 | 46,920.63 |
| 减:营业外支出 | 96,736.48 | 11,489.28 | 412.07 | 64,326.26 |
| 五、利润总额 | -10,715,018.11 | -9,021,535.22 | -3,238,317.86 | -23,298,033.22 |
| 减:所得税费用 | 1,252.5 | 1,252.5 | 1,252.5 | 644,661.46 |
| 六、净利润 | -10,716,270.61 | -9,022,787.72 | -3,239,570.36 | -23,942,694.68 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -10,716,270.61 | -9,022,787.72 | -3,239,570.36 | -23,942,694.68 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -10,716,270.61 | -9,022,787.72 | -3,239,570.36 | -23,942,694.68 |
| 扣除非经常损益后的净利润 | -15,428,361.48 | -11,967,716.47 | -4,661,761 | -30,195,256.46 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.1 | -0.08 | -0.03 | -0.22 |
| (二)稀释每股收益 | -0.1 | -0.08 | -0.03 | -0.22 |
| 九、综合收益总额 | -10,716,270.61 | -9,022,787.72 | -3,239,570.36 | -23,942,694.68 |
| 归属于母公司股东的综合收益总额 | -10,716,270.61 | -9,022,787.72 | -3,239,570.36 | -23,942,694.68 |
| 公告日期 | 2025-10-27 | 2025-08-25 | 2025-04-28 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |